Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — The dark-money group that has spent over $1 million on mysterious, pharma-bashing radio ads was formed by a top executive and a top lobbyist for the American Hospital Association and a former political consultant for CVS Health, according to a 2018 tax filing released to STAT this week.

The secretive group, known as Citizens for Truth in Drug Pricing, has blanketed airwaves with radio advertisements and sponsored commentary that sharply criticizes drug companies for high prices. It has also paid numerous well-known radio hosts, including the conservative personality Hugh Hewitt, to post Facebook ads urging voters to sign a petition to “stop drug companies from overcharging” and warning lawmakers they “risk reelection in 2020” if they do not support drug pricing reforms.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The plug being pulled on ending drug rebates may also have something to do with the fact that Medicare really wants to get beneficiaries into managed care. Drug rebates, if used to subsidize premiums as plan sponsors claim, help further that goal. The ugly part is that we have a situation of the sick (those paying inflated list prices for rebated prescriptions) subsidizing the premiums of all, including the healthy.

  • All the pieces to the puzzle are falling into place as to why President Trump, as
    he said “Pulled the Plug on the Drug Rebate issue”.

Comments are closed.